Clinical trial
The GLasses Against Transmission of SARS-CoV-2 (COVID-19) in the communitY (GLASSY) Trial: A Pragmatic Randomized Trial
NCT05217797 is registered in ClinicalTrials.gov with Norwegian Institute of Public Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The GLasses Against Transmission of SARS-CoV-2 (COVID-19) in the communitY (GLASSY) Trial: A Pragmatic Randomized Trial
- Lead sponsor
- Norwegian Institute of Public Health
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 2, 2021
- Completion date
- December 1, 2022
- Enrollment
- 3,717 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.